PRTA Q3'26 Earnings: EPS estimate is (0.23) USD

What happened

Prothena Corporation plc is scheduled to announce its Q3'26 results on October 29 at 8:00 AM ET. The revenue estimate is 9.58 million USD and the EPS estimate is (0.23) USD.

Confirmed

Global impact / market context

Investors use these estimates to judge whether Prothena will beat or miss expectations. Analysts expect a loss, meaning costs are forecast to exceed revenue, so a surprise on either line could move the share price.

Analyst inference

Recent quarters show wide swings: revenue beat estimates sharply in early 2026 after earlier misses, and reported EPS moved from losses to a profit. This history suggests results can differ greatly from forecasts.

Analyst inference

What to watch

1. Watch whether reported Q3'26 revenue lands above or below the 9.58 million USD estimate and how reported EPS compares with the (0.23) USD estimate. Confirmed
2. Watch how management explains spending plans tied to drug research, because higher capital spending would raise costs and widen losses if revenue does not grow. Proposed
3. Watch whether reported cash needs grow, since continued losses could push the company to raise money by borrowing or selling shares, affecting investors. Analyst inference

Evidence

• Original source link unavailable